Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese

Hypertension Research

Volumn 29, Issue 1, 2006, Pages 29-37

  Tsubakimoto, Akiko ^a   Saito, Isao ^a   Mannami, Toshifumi ^b   Naito, Yoshihiko ^c   Nakamura, Shinobu ^a   Dohi, Yoshiko ^a   Yonemasu, Kunio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Brachial ankle pulse wave velocity; Epidemiology; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTICLE; BODY FAT; BRACHIAL ARTERY; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PRACTICE GUIDELINE; PRESSURE MEASUREMENT; PULSE WAVE; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAVEFORM;

ADULT; AGED; ANKLE; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL PLEXUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; JAPAN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 33645217503     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.29     Document Type: Article

References (35)

1. Oliver JJ, Webb DJ: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554-566.
2. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE: Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426-444.
3. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
4. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-3390.
5. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME: Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046-2050.
6. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005; 28: 27-34.
7. Tomiyama H, Yamashina A, Arai T, et al: Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
8. Ohmori K, Emura S, Takashima T: Risk factors of atherosclerosis and aortic pulse wave velocity. Angiology 2000; 51: 53-60.
9. Yamashina A, Tomiyama H, Arai T, et al: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
10. Ohnishi H, Saitoh S, Takagi S, et al: Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose the Tanno and Sobetsu study. Diabetes Care 2003; 26: 437-440.
11. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M: Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003; 26: 163-167.
12. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
13. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005; 365: 1415-1428.
14. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program - Adult Treatment Panel III to Japanese men: the Tanno and Sobetsu study. Hypertens Res 2005; 28: 203-208.
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
16. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
17. 'Metabolic Syndrome' Shindan-Kijun Kentou Iinkai (Expert Committee on the Diagnosis and Classification of Metabolic Syndrome): 'Metabolic Syndrome' No Teigi To Shindan-Kijun (Guideline for diagnosis of metabolic syndrome). Nihon Naika Gakkai Zasshi 2005; 94: 794-809 (in Japanese).
18. Nakanishi N, Suzuki K, Tatara K: Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology 2003; 54: 551-559.
19. Nakanishi N, Shiraishi T, Wada M: Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh study. Hypertens Res 2005; 28: 125-131.
20. Nakamura M, Sato S, Shimamoto T: Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003; 10: 145-153.
21. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
22. Prineas RJ, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Bristol, John Wright & Sons, 1982, 229 pp.
23. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
24. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
25. Kitamura, A, Iso H, Iida M, et al: Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med 2002; 112: 104-119.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
27. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C: Relation between insulin and aortic stiffness: a population-based study. J Hum Hypertens 2004; 18: 1-7.
28. Sengstock DM, Vaitkevicius PV, Supiano MA: Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab 2005; 90: 2823-2827.
29. Ahluwalia N, Drouet L, Ruidavets JB, et al: Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis (available on-line 29 August 2005).
30. Okamura T, Moriyama Y, Kadowaki T, Kanda H, Ueshima H: Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with alpha-tocopherol in Japanese middle-aged male workers. Hypertens Res 2004; 27: 173-180.
31. Tomiyama H, Koji Y, Yambe M, et al: Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005; 45: 997-1003.
32. Sattar N, Williams K, Sniderman AD, D'Agostino R Jr, Haffner SM: Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 2004; 110: 2687-2693.
33. Ho RC, Davy K, Davy B, Melby CL: Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. Metabolism 2002; 51: 1478-1483.
34. Friedlander Y, Kidron M, Caslake M, Lamb T, McConnell M, Bar-On H: Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000; 148: 141-149.
35. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T, Yamashita T: Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol 2000; 29: 837-844.